William Ford, MD
Internal Medicine · Abington, PANPI 1225067960
Payments from drug & device makers
Across 89 payments — averaging $397.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$27K
- AstraZeneca$4K
- Novo Nordisk$2K
- Novartis$297
- Indivior Inc.$262
- Pfizer$206
- plus $710 from 13 others
What the payments were for
- Consulting fees$33,29494%
- Food & beverage$2,0396%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 27 | $27,304 |
| AstraZeneca | 5 | $4,141 |
| Novo Nordisk | 2 | $2,413 |
| Novartis | 16 | $297 |
| Indivior Inc. | 4 | $262 |
| Pfizer | 12 | $206 |
| AbbVie(2 entities) | 2 | $134 |
| Boehringer Ingelheim | 5 | $98 |
| Aimmune Therapeutics, Inc. | 2 | $91 |
| Vertex | 1 | $78 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $61 |
| Madrigal Pharmaceuticals | 1 | $50 |
| La Jolla Pharmaceutical Company | 2 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Smith+Nephew | 2 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| Philips North America LLC | 1 | $23 |
| Amgen | 1 | $21 |
| Bayer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$35,333 in reported general payments places this provider in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Abington
- Jonathan EpsteinPhiladelphia$13.1M
- Siddharth ShethPittsburgh$11M
- Nathan PatelTannersville$9.5M
- Pitamber DevgonPhiladelphia$7.5M
- Christopher StillDanville$7.1M
- Liza VillaruzPittsburgh$6.6M
- Paul HartleyUniontown$4.9M
- Victor KoladeSayre$4.7M
- Michael OliverBeaver$4.7M
- Raman PurighallaPittsburgh$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.